- Investing Ideas
- /
- Global Big Pharma, Big Dividends
Global Big Pharma, Big Dividends
Results
80
80 companies
Grand Pharmaceutical Group
Market Cap: HK$22.2b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$6.33
7D
3.3%
1Y
55.5%
Chengdu Kanghong Pharmaceutical Group
Market Cap: CN¥24.4b
Research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China.
002773
CN¥26.54
7D
9.8%
1Y
51.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥40.2b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥89.36
7D
6.1%
1Y
94.0%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany.
DMP
€36.50
7D
-4.2%
1Y
10.9%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.6b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€51.30
7D
-1.3%
1Y
-36.5%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹484.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,735.75
7D
-4.9%
1Y
41.0%
Haw Par
Market Cap: S$2.9b
Manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally.
H02
S$12.80
7D
-3.1%
1Y
30.9%
Gland Pharma
Market Cap: ₹256.9b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹1,474.85
7D
-7.4%
1Y
-15.9%